SB 678 — Prescription Insulin Drugs
Last action — Died in Banking and Insurance
-
✓Introduced
-
2In Committee
-
3Passed Senate
-
4Passed House
-
5To Executive
-
6Enacted
This bill died with 2022 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
Summary
Prescription Insulin Drugs; Requiring individual and group health insurance policies, respectively, to cap an insured’s monthly cost-sharing obligation for covered prescription insulin drugs at a specified amount; providing that coverage for prescription insulin drugs may not be subject to a deductible; requiring health benefit plans that cover small employers to comply with prescription insulin drug cost-sharing requirements; requiring health maintenance contracts to cap a subscriber’s monthly cost-sharing obligation for covered prescription insulin drugs at a specified amount, etc.
Bill Text
- Introduced S 678 Filed Current pdf
Action History
-
Died in Banking and Insurance
-
Indefinitely postponed and withdrawn from consideration
-
Introduced
-
Referred to Banking and Insurance; Appropriations Subcommittee on Agriculture, Environment, and General Government; Appropriations
-
Filed
Sponsors
- Cruz · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 163 not signed on
Sponsors (1)
- Cruz
Co-sponsors (0)
None.
Not signed on (163)
163 members have not signed on to this bill.
Show all 163 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does SB 678 do?
- Prescription Insulin Drugs; Requiring individual and group health insurance policies, respectively, to cap an insured’s monthly cost-sharing obligation for covered prescription insulin drugs at a specified amount; providing that coverage for prescription insulin drugs may not be subject to a deductible; requiring health benefit plans that cover small employers to comply with prescription insulin drug cost-sharing requirements; requiring health maintenance contracts to cap a subscriber’s monthly cost-sharing obligation for covered prescription insulin drugs at a specified amount, etc.
- Who sponsors SB 678?
- SB 678 is sponsored by Cruz.
- What is the current status of SB 678?
- This bill died with 2022 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track SB 678?
- Track SB 678 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on SB 678
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of SB 678
Last checked for changes 2 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →